Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF Valuation
Base-case fair value
€5.96
Intrinsic €7.95 · 25% MOS
Current price: €4.65
Base-case summary
Our base-case DCF for Faes Farma, S.A. (FAE.XMAD) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 22.1% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from €55M in trailing free cash flow, this produces an intrinsic value of €7.95 per share. A 25% safety margin gives a fair value of €5.96, suggesting the stock is currently 28% undervalued against the €4.65 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
€55M
Cash & equivalents
€130M
Total debt
€426M
Shares outstanding
311M